Novel bioabsorbable polymer and polymer-free metallic drug-eluting stents
نویسندگان
چکیده
منابع مشابه
New drug-eluting stents: polymer-free, biodegradable polymers or bioabsorbable scaffolds?
The advent of stents in interventional cardiology has contributed to excellent initial angiographic outcomes in all lesions, avoiding acute or subacute vessel occlusion and significantly reducing angiographic and clinical restenosis. Perhaps paradoxically, stents have been found to induce greater neointimal proliferation than balloon angioplasty. In fact, the best results are based on the virtu...
متن کاملBiodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents
BACKGROUND Even if drug-eluting stents (DES) showed beneficial effects in patients with coronary artery diseases (CADs), limitations have been observed with the first-generation durable polymer DES (DP-DES). Recently, biodegradable polymer DES (BP-DES) have been approved to be used as an alternative to DP-DES, with potential benefits. We aimed to systematically compare BP-DES with the first-gen...
متن کاملAdverse cardiovascular events associated with biodegradable polymer drug-eluting stents and durable polymer everolimus-eluting stents
BACKGROUND Controversies have been observed among network meta-analyses comparing biodegradable polymer drug-eluting stents (BP-DES) with durable polymer drug-eluting stents (DP-DES). We aimed to compare the adverse cardiovascular events associated with BP-DES and durable polymer everolimus-eluting stents (DP-EES) using a large number of patients obtained from randomized controlled trials (RCTs...
متن کاملThrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents.
BACKGROUND Acute thrombogenicity and re-endothelialization represent clinically relevant end points pertaining to the safety of coronary stents, which have not been compared among biodegradable polymer-based drug-eluting metallic stents and fully bioabsorbable scaffolds to date. METHODS AND RESULTS We investigated comparative outcomes with respect to acute thrombogenicity and re-endothelializ...
متن کامل2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
OBJECTIVES In the ISAR-TEST-2 (Intracoronary Stenting and Angiographic Results: Test Efficacy of Three Limus-Eluting Stents) randomized trial, a new-generation sirolimus- and probucol-eluting stent (Dual-DES) demonstrated a 12-month efficacy that was comparable to sirolimus-eluting stents (SES) (Cypher, Cordis Corp., Warren, New Jersey) and superior to zotarolimus-eluting stents (ZES) (Endeavor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiology
سال: 2018
ISSN: 0914-5087
DOI: 10.1016/j.jjcc.2017.12.007